Skip to main content

Investor Relations

Investors

Liberty Defense is working toward a safer future, secure from acts of violent crime and terrorism, by developing next generation threat detection using disruptive technology to detect concealed weapons.

Nasdaq

DETX

TSX Venture

SCAN

Quotes are delayed.

Financial reports

Financial statements and MD&A

Access our annual and quarterly financial statements and management’s discussion and analysis documents.

2026

Q2 Financial StatementPeriod ended June 30, 2026
Q2 MD&APeriod ended June 30, 2026
Q1 Financial StatementPeriod ended March 31, 2026
Q1 MD&APeriod ended March 31, 2026

2025

Q4 Financial StatementPeriod ended December 31, 2025
Q4 MD&APeriod ended December 31, 2025
Q3 Financial StatementPeriod ended September 30, 2025
Q3 MD&APeriod ended September 30, 2025
Q2 Financial StatementPeriod ended June 30, 2025
Q2 MD&APeriod ended June 30, 2025
Q1 Financial StatementPeriod ended March 31, 2025
Q1 MD&APeriod ended March 31, 2025

2024

Q4 Financial StatementPeriod ended December 31, 2024
Q4 MD&APeriod ended December 31, 2024
Q3 Financial StatementPeriod ended September 30, 2024
Q3 MD&APeriod ended September 30, 2024
Q2 Financial StatementPeriod ended June 30, 2024
Q2 MD&APeriod ended June 30, 2024
Q1 Financial StatementPeriod ended March 31, 2024
Q1 MD&APeriod ended March 31, 2024

2023

Q4 Financial StatementPeriod ended December 31, 2023
Q4 MD&APeriod ended December 31, 2023
Q3 Financial Statement Period ended September 30, 2023
Q3 MD&APeriod ended September 30, 2023
Q2 Financial Statement Period ended June 30, 2023
Q2 MD&APeriod ended June 30, 2023
Q1 Financial Statement Period ended March 31, 2023
Q1 MD&APeriod ended March 31, 2023

2022

Q4 Financial StatementPeriod ended December 31, 2022
Q4 MD&APeriod ended December 31, 2022
Q3 Financial StatementPeriod ended September 30, 2022
Q3 MD&APeriod ended September 30, 2022
Q2 Financial StatementPeriod ended June 30, 2022
Q2 MD&APeriod ended June 30, 2022
Q1 Financial StatementPeriod ended March 31, 2022
Q1 MD&APeriod ended March 31, 2022

2021

Q4 Financial StatementPeriod ended December 31, 2021
Q4 MD&APeriod ended December 31, 2021
Q3 Financial StatementPeriod ended September 30, 2021
Q3 MD&APeriod ended September 30, 2021
Q2 Financial StatementPeriod ended June 30, 2021
Q2 MD&APeriod ended June 30, 2021
Q1 Financial StatementPeriod ended March 31, 2021
Q1 MD&APeriod ended March 31, 2021

2020

Q4 – Financial StatementPeriod ended December 31, 2020
Q4 – MD&APeriod ended December 31, 2020
Q3 – Financial StatementPeriod ended September 30, 2020
Q3 – MD&APeriod ended September 30, 2020
Q2 – Financial StatementPeriod ended June 30, 2020
Q2 – MD&APeriod ended June 30, 2020
Q1 – Financial StatementPeriod ended March 31, 2020
Q1 – MD&APeriod ended March 31, 2020

2019

Annual Financial StatementPeriod ended March 12, 2020
Annual MD&APeriod ended March 12, 2020
Q3 – Financial StatementPeriod ended November 7, 2019
Q3 – MD&APeriod ended November 7, 2019
Q2 – Financial StatementPeriod ended August 1, 2019
Q2 – MD&APeriod ended August 1, 2019
Q1 – Financial StatementPeriod ended May 16, 2019
Q1 – MD&APeriod ended May 16, 2019

2018

Annual Financial StatementPeriod ended March 5, 2019
Annual MD&APeriod ended March 5, 2019
Q3 – Financial StatementPeriod ended November 29, 2018
Q3 – MD&APeriod ended November 29, 2018
Q2 – Financial StatementPeriod ended August 29, 2018
Q2 – MD&APeriod ended August 29, 2018
Q1 – Financial StatementPeriod ended May 30, 2018
Q1 – MD&APeriod ended May 30, 2018

2017

Annual Financial StatementPeriod ended April 30, 2018
Annual MD&APeriod ended April 30, 2018
Q3 – Financial StatementPeriod ended November 29, 2017
Q3 – MD&APeriod ended November 29, 2017
Q2 – Financial StatementPeriod ended August 28, 2017
Q2 – MD&APeriod ended August 28, 2017
Q1 – Financial StatementPeriod ended May 29, 2017
Q1 – MD&APeriod ended May 29, 2017

2016

Annual Financial StatementPeriod ended April 20, 2017
Annual MD&APeriod ended April 20, 2017
Q3 – Financial StatementPeriod ended November 29, 2016
Q3 – MD&APeriod ended November 29, 2016
Q2 – Financial StatementPeriod ended August 25, 2016
Q2 – MD&APeriod ended August 25, 2016
Q1 – Financial StatementPeriod ended May 31, 2016
Q1 – MD&APeriod ended May 31, 2016

2015

Annual Financial StatementPeriod ended April 17, 2016
Annual MD&APeriod ended April 17, 2016
Q3 – Financial StatementPeriod ended December 2, 2015
Q3 – MD&APeriod ended December 2, 2015
Q2 – Financial StatementPeriod ended August 28, 2015
Q2 – MD&APeriod ended August 28, 2015
Q1 – Financial StatementPeriod ended May 26, 2015
Q1 – MD&APeriod ended May 26, 2015

2014

Annual Financial StatementPeriod ended April 27, 2015
Annual MD&APeriod ended April 27, 2015
Q3 – Financial StatementPeriod ended November 27, 2014
Q3 – MD&APeriod ended November 27, 2014
Q2 – Financial StatementPeriod ended August 27, 2014
Q2 – MD&APeriod ended August 27, 2014
Q1 – Financial StatementPeriod ended May 29, 2014
Q1 – MD&APeriod ended May 29, 2014

2013

Annual Financial StatementPeriod ended April 8, 2014
Annual MD&APeriod ended April 8, 2014
Q3 – Financial StatementPeriod ended November 26, 2013
Q3 – MD&APeriod ended November 26, 2013
Q2 – Financial StatementPeriod ended August 29, 2013
Q2 – MD&APeriod ended August 29, 2013
Q1 – Financial StatementPeriod ended June 13, 2013
Q1 – MD&APeriod ended June 13, 2013

Stock information

Share structure and warrants

Shares outstanding, warrants and stock quotes for Nasdaq: DETX and TSXV: SCAN.

Investor contacts

Investor Relations

Kevin O’Dowd

Email alerts

Get Liberty Defense news and investor updates by email.

You can unsubscribe at any time from the link at the bottom of every email.